Home › Trial NCT07563010
Menin-Inhibitor Targeted Maintenance in AML
- Trial IDNCT07563010
- StatusNot Yet Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorCenter for International Blood and Marrow Transplant Research
- Enrollment146
- Start date2026-12
- ConditionsRelapsed Adult AML · Stem Cell Transplant Complications · Acute Myeloid Leukemia · Transplant-Related Hematologic Malignancy
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.